Is venetoclax a new wonder drug in CLL?

Br J Haematol. 2019 May;185(4):643-646. doi: 10.1111/bjh.15836. Epub 2019 Mar 11.

Authors

Chris Fegan¹, Chris Pepper²

Affiliations

¹ Institute of Cancer and Genetics, School of Medicine, Cardiff, CF14 4XN, UK.
² Brighton and Sussex Medical School, University of Sussex, Brighton, BN1 9PX, UK.

PMID: 30859555
DOI: 10.1111/bjh.15836

No abstract available

Keywords: CLL; differentiated cell; venetoclax.

Publication types

Editorial
Comment

MeSH terms

Bridged Bicyclo Compounds, Heterocyclic
Humans
Leukemia, Lymphocytic, Chronic, B-Cell*
Sulfonamides

Substances

Bridged Bicyclo Compounds, Heterocyclic
Sulfonamides
venetoclax